Hormone Receptor Positive HER-2 Negative Breast Cancer
13 clinical trials · Condition
◉ Watch Hormone Receptor Positive HER-2 Negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Real-world Study of Effectiveness and Safety in HR+/HER2- Breast Cancer Patients Treated With Ribociclib or Alpelisib (NCT06705504) | Novartis | 2021-06-11 |
| Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast Cancer (NCT02692755) | Georgetown University | 2016-09-01 |
Track Hormone Receptor Positive HER-2 Negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.